Evidence map›Paper›PMID 22123950›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Palmitoylation influences the function and pharmacology of sodium channels.

Frank Bosmans, Mirela Milescu, Kenton J Swartz

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Cytoskeletal scaffolding of NaCurrent opinion in cell biology · 2025
    Review
  2. Article
  3. Mechanisms and functions of protein S-acylation.Nature reviews. Molecular cell biology · 2024
    Review
  4. Article
  5. Review
  6. Palmitoylation of Voltage-Gated Ion Channels.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Functional cross-talk between phosphorylation and disease-causing mutations in the cardiac sodium channel NaProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. Article
  10. Article
  11. The Journal of biological chemistry · 2020
    Article
  12. Review
  13. Selective NaProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. The NaFrontiers in pharmacology · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Frank BosmansMolecular Physiology and Biophysics Section, Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. bosmansf@ninds.nih.gov
Mirela Milescu
Kenton J Swartz
National Institute of Neurological Disorders and Stroke · USNational Institutes of Health · US

Funding

Gating mechanisms and pharmacology of sodium and calcium channelsZIANS003017 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SWARTZ, KENTON · 2009 to 2014
$3.3M
6 · The paper itself

Abstract

Palmitoylation is a common lipid modification known to regulate the functional properties of various proteins and is a vital step in the biosynthesis of voltage-activated sodium (Nav) channels. We discovered a mutation in an intracellular loop of rNav1.2a (G1079C), which results in a higher apparent affinity for externally applied PaurTx3 and ProTx-II, two voltage sensor toxins isolated from tarantula venom. To explore whether palmitoylation of the introduced cysteine underlies this observation, we compared channel susceptibility to a range of animal toxins in the absence and presence of 2-Br-palmitate, a palmitate analog that prevents palmitate incorporation into proteins, and found that palmitoylation contributes to the increased affinity of PaurTx3 and ProTx-II for G1079C. Further investigations with 2-Br-palmitate revealed that palmitoylation can regulate the gating and pharmacology of wild-type (wt) rNav1.2a. To identify rNav1.2a palmitoylation sites contributing to these phenomena, we substituted three endogenous cysteines predicted to be palmitoylated and found that the gating behavior of this triple cysteine mutant is similar to wt rNav1.2a treated with 2-Br-palmitate. As with chemically depalmitoylated rNav1.2a channels, this mutant also exhibits an increased susceptibility for PaurTx3. Additional mutagenesis experiments showed that palmitoylation of one cysteine in particular (C1182) primarily influences PaurTx3 sensitivity and may enhance the inactivation process of wt rNav1.2a. Overall, our results demonstrate that lipid modifications are capable of altering the gating and pharmacological properties of rNav1.2a.

Indexed as

LipoylationAnimalsCholesterolCysteineIntracellular SpaceIon Channel GatingMutant ProteinsMutationNAV1.2 Voltage-Gated Sodium ChannelNerve Tissue ProteinsRatsSodium ChannelsSpider VenomsXenopusCholesterolCysteineMutant ProteinsNAV1.2 Voltage-Gated Sodium ChannelNerve Tissue ProteinsScn2A protein, ratSodium ChannelsSpider Venoms

Identifiers

PMID22123950
PMCPMC3250191
OpenAlexW2033852302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.